Skip to main content

Animations

MJFF Publications

2071 - 2080 of 9131 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • Summary Details
    OPEN
    Title: A validation study of the Clinician's Tardive Inventory (CTI)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107812
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Lifestyle factors and clinical severity of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-31531-w
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1130833
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02585-x
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
    Journal Name: Journal of Patient-Reported Outcomes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s41687-023-00577-9
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01563-4
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000207077
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model ofGBA1-associated Parkinson’s disease
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddad025
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13751
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Substitution of PINK1 Gly411 modulates substrate receptivity and turnover
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2151294
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.